Le Lézard
Classified in: Science and technology
Subjects: Conference, Event, Trade Show

Award-Winning Actress Viola Davis to Keynote Indeed FutureWorks 2023


Indeed, the #1 job site in the world, returns to host Indeed FutureWorks 2023, an annual industry conference focused on how the world can work better. The event will be held September 20-21 in Atlanta at The Georgia World Congress Center and will also be broadcast live to HR and talent leaders around the world. Registration is now open at IndeedFutureWorks.com.

Indeed FutureWorks 2023 will bring together diverse thinkers, inspirational leaders, and HR peers from all across the globe. During the conference, these industry experts will discuss a wide variety of topics ranging from ever-evolving hiring practices to how the world can work better. Sessions at the event will also cover specific opportunities and challenges arising from the evolution and rapid growth of AI and how AI helps employers hire faster and simpler.

"At Indeed, we help people get jobs. As we look to the future, the labor market will remain tight for years to come. At FutureWorks, we will lead the discussion on how the way we work is evolving, factors influencing workers and employers, and the enormous potential for responsible AI to help the future of work," said Indeed CEO, Chris Hyams.

This year's keynote will feature award-winning actress, author, and visionary, Viola Davis, who will sit down with Indeed Chief Marketing Officer Jessica Jensen for a fireside chat titled "Authenticity in the Age of Algorithms." In this session, the two will share lessons learned and how we can remain human in an increasingly automated world.

In addition to Viola Davis, other guest speakers include:

Indeed executives will take the stage throughout the conference to discuss timely and thought-provoking sessions including:

With 23 people hired every minute1, Indeed is the strategic talent partner to help employers get to the hire faster and more efficiently. Indeed FutureWorks is open to all HR practitioners, talent acquisition professionals, recruiters, executives, and anyone involved in hiring and the future of work. The full agenda and tickets for both in-person and virtual experiences are available at IndeedFutureWorks.com.

About Indeed

More people find jobs on Indeed than anywhere else. Indeed is the #1 job site in the world (Comscore, Total Visits, June 2023) and allows job seekers to search millions of jobs in more than 60 countries and 28 languages. Almost 3.5 million2 employers use Indeed to find and hire new employees. More than 300 million unique visitors use Indeed each month to search for jobs, post resumes, research companies and more.

1Indeed data, 2022 average (worldwide)

2Indeed data, 2022 (worldwide)


These press releases may also interest you

at 21:09
On June 29, the "Gather Great Wisdom to Shape the Future of Intelligent Manufacturing?Special Exhibition on Design Intelligence and High Quality Development", hosted by the China Academy of Art (CAA), opened at the National Museum of China in...

at 20:55
Intermap Technologies ("Intermap" or the "Company"), a global leader in 3D geospatial products and intelligence solutions, announces a new financing. The Company is offering up to a maximum of 4,300,000 Class "A" common shares of the Company...

at 20:45
"The Classic Quotes by Xi Jinping," a multilingual TV show produced by China Media Group, aired in Kazakhstan on Tuesday after Chinese...

at 20:07
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...

at 20:05
Enterprises in Asia Pacific are moving toward software-defined networking (SDN) to make communication more secure and resilient and speed up business decision-making, according to a new research report published today by Information Services Group...

at 20:00
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal...



News published on and distributed by: